"10.1371_journal.pone.0076094","plos one","2013-09-25T00:00:00Z","Florian Riese; Sonja Grinschgl; Manuel T Gersbacher; Natalie Russi; Christoph Hock; Roger M Nitsch; Uwe Konietzko","Division of Psychiatry Research and Psychogeriatric Medicine, University of Zurich, Zurich, Switzerland","Conceived and designed the experiments: FR UK. Performed the experiments: FR SG MTG NR UK. Analyzed the data: FR SG MTG NR CH RMN UK. Wrote the manuscript: FR UK. Critically revised the manuscript: SG MTG NR CH and RMN.","Christoph Hock is a co-founder and serves as board member and holds patents and stock fromNeurimmune AG, Schlieren. Roger Nitsch is founder and president and holds patents and stock fromNeurimmune AG, Schlieren. Neurimmune AG develops human antibodies to treat neurodegenerative diseases. The submitted research paper has no connection to the work performed at Neurimmune AG. Therefore, it does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Florian Riese, Sonja Grinschgl, Manuel Gersbacher, Natalie Russi and Uwe Konietzko declare no competing interests.","2013","09","Florian Riese","FR",7,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
